Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87,001,862
-
Total 13F shares
-
9,877,148
-
Share change
-
+128,295
-
Total reported value
-
$58,241,000
-
Price per share
-
$5.90
-
Number of holders
-
29
-
Value change
-
+$736,496
-
Number of buys
-
11
-
Number of sells
-
6
Institutional Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q4 2016
As of 31 Dec 2016,
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,877,148 shares.
The largest 10 holders included
FMR LLC, EcoR1 Capital, LLC, Partner Fund Management, L.P., Clough Capital Partners L P, Boxer Capital, LLC, VANGUARD GROUP INC, Minerva Advisors LLC, MORGAN STANLEY, Alethea Capital Management, LLC, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.